Hims & Hers Health Stock Drops After Missing Earnings Despite Raised Guidance
Hims & Hers Health stock fell sharply after reporting a significant loss in Q1 earnings despite raising its annual sales guidance. The telehealth company lost $0.40 per share and reported revenue of $608 million, missing analyst expectations.

Topics: GLP-1 drugs stock decline telehealth